Resource
Independent research is the backbone of informed decision-making. It facilitates transparency in an often clouded industry. Be a part of something bigger by participating…
Read Post
Blog
The Inflation Reduction Act (IRA) is the most significant piece of legislation to impact the Medicare program since the inception…
Read Post
Blog
Sickle Cell Disease Sickle cell disease is an inherited blood disorder that impacts over 100,000 people in the United States and is most common…
Read Post
Resource
GLP-1 drugs have emerged as a highly effective treatment for type 2 diabetes and, more recently, weight loss. Due to their success in weight…
Read Post
Blog
PBMs have recently announced the changes to their formulary for the year 2024, which will take effect 1/1/2024. In light of these changes, PSG…
Read Post
Blog
Get the Full Analysis of the other Big 3 Formulary Changes: CVS Health Optum Rx…
Read Post
Blog
Get the Full Analysis of the other Big 3 Formulary Changes: CVS Health Express Scripts…
Read Post
Blog
Get the Full Analysis of the other Big 3 Formulary Changes: Express Scripts Optum Rx…
Read Post
Blog
And then there were two… Eli Lilly has received FDA approval for the next weight loss drug. Tirzepatide, on the…
Read Post
Case Study
Key Metrics: 2.5% decrease in PMPM gross cost $11M dollars of savings Background A plan came to PSG with concerns that pharmacy costs were…
Read Post
Industry Report
Discover trends, emerging opportunities, and strategies plan sponsors need to know to best manage their pharmacy benefits. The pharmacy landscape is complex, changing,…
Read Post